Mirae Asset Global Investments Co., Ltd. Oric Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,013 shares of ORIC stock, worth $21,478. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,013Holding current value
$21,478% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ORIC
# of Institutions
112Shares Held
63.1MCall Options Held
0Put Options Held
0-
Nextech Invest Ag5.29MShares$56.4 Million7.05% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$51.5 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$46.9 Million3.41% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.14MShares$44.2 Million1.73% of portfolio
-
Viking Global Investors LP4MShares$42.7 Million0.11% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $422M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...